Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BP vs GSK✓SelectedUSD · GSKBP vs GSK performance historyLatest closeAs of-0.16%11/17
Stock and ETF performance explorer

BP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+109.7%
GSK return
+43.9%
Excess return
+65.8%
Maximum drawdown
-30.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.2%-2.3%+2.2%+0.2%
7D+1.8%-3.0%+4.8%+2.3%
30D-9.6%+0.4%-10.0%-9.8%
3M+5.9%-1.2%+7.1%+5.8%
6M+3.5%+0.9%+2.6%+2.8%
YTD+35.5%+4.0%+31.5%+32.4%
1Y+28.9%+7.3%+21.6%+25.1%
3Y+47.9%+57.1%-9.2%+25.6%
5Y+109.7%+43.0%+66.8%+77.2%
All+109.7%+43.9%+65.8%+77.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling